|Bid||24.27 x 1100|
|Ask||24.35 x 800|
|Day's range||23.14 - 24.38|
|52-week range||19.71 - 40.12|
|Beta (5Y monthly)||1.04|
|PE ratio (TTM)||41.98|
|Earnings date||08 Feb 2024 - 12 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||26.27|
Down 41% and 53% from their 52-week highs, these two market-leading stocks are primed for a rebound.
Medpace, Doximity and Biodesix have been highlighted in this Industry Outlook article.
Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.